Skip to content

A study to assess the efficacy of a probiotic in the restoration of bowel function of patients undergoing reversal of ileostomy.

A study to assess the efficacy of VSL#3 in the restoration of bowel function of patients undergoing reversal of ileostomy.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000932066
Enrollment
40
Registered
2010-11-03
Start date
2005-03-02
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Patients experience a period of altered bowel function after the reversal of a temporary loop ileostomy. This study aimed to assess whether a probiotic preparation, VSL#3, improved bowel function during the first month after loop ileostomy reversal.

Interventions

VSL#3 Dosage: 2.5g sachet twice daily for 4 weeks Ingredients: 450 billion lactic acid bacteria, cornstarch Mode: orally mixed with water or apple juice

Sponsors

The Queen Elizabeth Hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Over 18 years of age 2. Able to fill in questionnaires and diary 3. Had an anterior resection or Hartmann's procedure 4. Undergoing reversal of ileostomy

Exclusion criteria

Patients with Coeliac Disease

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026